All Pharma News
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
08 May 2023
Share Share
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
03 Apr 2023
Share Share
TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results

TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results
GLOBENEWSWIRE
23 Mar 2023
Share Share
Adaptimmune & TCR² Announce Combination to Create Cell Therapy Company

Adaptimmune & TCR² Announce Combination to Create Cell Therapy Company
GLOBENEWSWIRE
06 Mar 2023
Share Share
TCR2 Therapeutics to Present at SVB Securities Global Biopharma Conference 2023

TCR2 Therapeutics to Present at SVB Securities Global Biopharma Conference 2023
GLOBENEWSWIRE
08 Feb 2023
Share Share
TCR² first began layoffs back in August

TCR² first began layoffs back in August
Max Bayer FIERCE BIOTECH
13 Jan 2023
Share Share
TCR² Therapeutics Announces Pipeline Priorities for 2023

TCR² Therapeutics Announces Pipeline Priorities for 2023
GLOBENEWSWIRE
05 Jan 2023
Share Share
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule

TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
GLOBENEWSWIRE
05 Jan 2023
Share Share
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule

TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
GLOBENEWSWIRE
01 Dec 2022
Share Share
TCR² Therapeutics to Present at the Piper Sandler Healthcare Conference

TCR² Therapeutics to Present at the Piper Sandler Healthcare Conference
GLOBENEWSWIRE
23 Nov 2022
Share Share